Stock Research: Equasens

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Equasens

ENXTPA:PHA FR0012882389
66
  • Value
    80
  • Growth
    9
  • Safety
    Safety
    50
  • Combined
    42
  • Sentiment
    86
  • 360° View
    360° View
    66
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Equasens SA, formerly Pharmagest Interactive SA, is a France-based company specializing in software solutions for healthcare. It operates in the healthcare IT sector, providing software for pharmacies, hospitals, and other health establishments. Its main region of operation is France. In the last fiscal year, the company had a market cap of $887 million, profits of $154 million, and revenue of $224 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 66 (better than 66% compared with alternatives), overall professional sentiment and financial characteristics for the stock Equasens are above average. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Equasens. The consolidated Value Rank has an attractive rank of 50, which means that the share price of Equasens is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 50% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 80. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 86. But the consolidated Growth Rank has a low rank of 9, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 91 of its competitors have better growth. ...read more

more
Index
CAC All
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
50 65 61 50
Growth
9 31 31 19
Safety
Safety
80 70 67 53
Sentiment
86 98 92 34
360° View
360° View
66 87 79 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
97 95 82 100
Opinions Change
8 50 50 50
Pro Holdings
n/a 77 80 1
Market Pulse
81 83 77 20
Sentiment
86 98 92 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
50 65 61 50
Growth
9 31 31 19
Safety Safety
80 70 67 53
Combined
42 65 51 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
65 67 56 56
Price vs. Earnings (P/E)
33 34 38 38
Price vs. Book (P/B)
57 50 46 38
Dividend Yield
77 84 86 68
Value
50 65 61 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
35 72 49 42
Profit Growth
30 8 46 53
Capital Growth
49 82 35 38
Stock Returns
17 31 17 15
Growth
9 31 31 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
64 57 51 41
Refinancing
47 31 37 33
Liquidity
88 88 92 79
Safety Safety
80 70 67 53

Similar Stocks

Discover high‑ranked alternatives to Equasens and broaden your portfolio horizons.

Rubis

ENXTPA:RUI
Country: France
Industry: Gas Utilities
Size: Medium
Full Stock Analysis

Ipsen

ENXTPA:IPN
Country: France
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Synergie

ENXTPA:SDG
Country: France
Industry: HR- & Employment Services
Size: Medium
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.